
NTR · NYSE
Reports Nov 4, 2026.
Consensus is $0.84 EPS for Sep 2026 across 6 estimates, ranging $0.61 to $1.01.
Nutrien's second quarter was a modest year-over-year operating decline wrapped in a better-than-expected per-share result. Supplied reported EPS of $2.67 exceeded the $2.57 consensus by 3.89%, although the release reports diluted IFRS EPS of $2.53 and adjusted EPS of $2.61. Sales increased 4% to $10.812 billion, but net earnings fell 1% to $1.222 billion and adjusted EBITDA declined 2% to $2.430 billion. The quarter was sharply stronger than the seasonally weak first quarter, when diluted EPS was $0.27 and adjusted EPS was $0.50.
The central positive was potash: higher benchmarks, record production and strong offshore demand lifted adjusted EBITDA 4% to $658 million, with first-half EBITDA up 15% to $1.236 billion. Retail remained structurally profitable but quarterly EBITDA slipped 2% as lower crop nutrient volumes and fuel costs offset proprietary-product gains. Nitrogen EBITDA declined 5% on volume disruptions, while phosphate EBITDA plunged 75% to $23 million as sulfur costs drove negative gross margin. Management raised potash volume guidance to 14.2–14.8 million tonnes and cut capital-spending guidance to $1.95–$2.05 billion, reinforcing the focus on cash generation and shareholder returns.